Page 166 - PRECONGRESS COURSE 06

166
Page 162 of 258
Do we need a testosterone RCT in poor responders?
 We are using it without any evidence or safety profile!!! 25.8% of the centres worldwide are using DHEA
Source: IVFworldwide.com
 Duration and dose of testosterone
Polyzos et al., Reprod Sciences 2016
TTRANSPORT trial
Testosterone TRANSdermal gel for Poor Ovarian Responders Trial
Double blind placebo controlled RCT 400 patients
 UZ Brussel
 Dexeus Barcelona
 Skive Denmark
 Quiron Madrid
 Univesity hospital of Basel  UZ Antwerp